No need to relabel existing medicine stock: FinMin on new GST rates

Business Standard

Recalling or re-labelling medicines already in the supply chain before September 22 will not be mandatory, the Finance Ministry said on Tuesday, issuing a fresh set of frequently asked questions (FAQs) to address industry concerns following the announcement of goods and services tax (GST) revisions.   “Recalling, re-labelling, or re-stickering on the label of container or pack of stocks relea…

Sign in to read the full article

Create a free account or sign in to access the complete content.